Search Results

You are looking at 41 - 50 of 178 items for :

  • Refine by Access: All Content x
Clear All

.02.008 . [Epub ahead of print] 5 Cascella M, Rajnik M, Cuomo A, et al. Features, evaluation and treatment Coronavirus (COVID-19). 2020 Mar 8. StatPearls [Internet]. Treasure Island (FL

Open access

Introduction The coronavirus disease 2019 (COVID-19) pandemic has had an unprecedented impact on the healthcare system worldwide [ 1 ]. Prevention of hospital-acquired infections is a critical and necessary task, especially during a pandemic

Open access
Orvosi Hetilap
Authors: Mariann Berhés, Ákos Fábián, István László, Tamás Végh, Csilla Molnár, Béla Fülesdi, and György Koszta

References 1 Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive

Open access

Introduction On March 11th, 2020, the World Health Organization (WHO) officially determined that COVID-19 should be characterized as a pandemic [ 1 ]. The first confirmed COVID-19 cases were reported in Wuhan, a city in Hubei Province in central

Open access
Journal of Behavioral Addictions
Authors: Ricardo B. Viana, Rodrigo L. Vancini, Wellington F. Silva, Naiane S. Morais, Vinnycius N. de Oliveira, Marília S. Andrade, and Claudio A. B. de Lira

We read with great interest the recent letter to the editor “ Problematic online gaming and the COVID-19 pandemic ” ( King et al., 2020 ) published in the Journal of Behavioral Addictions . The authors expressed their concern about the increase in

Open access

Az új típusú koronavírus okozta megbetegedés (COVID–19): összefoglaló hematológusoknak II. – a diagnosztika, terápia és prevenció lehetőségei

The novel coronavirus disease (COVID-19): a review for specialists in hematology II – aspects of diagnosis, therapy and prevention

Hematológia–Transzfuziológia
Authors: Bálint Gergely Szabó, Ilona Bobek, Marienn Réti, László Gopcsa, Dóra Mathiász, Botond Lakatos, Gabriella Bekő, Mónika Pető, János Sinkó, Gábor Mikala, Zoltán Kis, János Szlávik, Péter Reményi, and István Vályi-Nagy

Irodalom 1 Szabó B. In the middle of a new pandemic – what we know about COVID-19. [Egy új világjárvány közepén – amit eddig a COVID–19-ről tudni

Open access
Acta Microbiologica et Immunologica Hungarica
Authors: Botond Lakatos, Balint Gergely Szabo, Ilona Bobek, Laszlo Gopcsa, Gabriella Beko, Noemi Kiss-Dala, Borisz Petrik, Zsofia Gaspar, Balazs Ferenc Farkas, Janos Sinko, Peter Remenyi, Janos Szlavik, and Istvan Valyi-Nagy

systemic corticosteroids, tocilizumab remains the only medication that has been shown to improve survival in severe and critically ill COVID-19 patients, probably due to its anti-inflammatory effects [ 2 ]. Earlier randomised controlled trials have

Open access
Orvosi Hetilap
Authors: Tamás Végh, István László, Marianna Juhász, Mariann Berhés, Ákos Fábián, György Koszta, Csilla Molnár, and Béla Fülesdi

–506. 2 Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective study. Lancet 2020; 395: 1054

Open access
Orvosi Hetilap
Authors: Ilona Bobek, László Gopcsa, Marienn Réti, Gabriella Bekő, Lilla Hancz, Botond Lakatos, Eszter Molnár, Sándor Nagy, Péter Reményi, Gabriella Sebestyén, János Sinkó, János Szlávik, Miklós Szolnoky, and István Vályi-Nagy

References 1 Váradi A, Ferenci T, Falus A. The coronavirus-induced COVID-19 pandemic. Previous experiences and scientific evidences at the end of March

Open access

SARS-CoV-2-fertőzés és COVID–19 Gaucher-kóros betegekben: a védőoltás javallata

SARS-CoV-2 infection and COVID‒19 in Gaucher disease: indications for vaccination

Orvosi Hetilap
Author: László Maródi

References 1 Centers for Disease Prevention and Control. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) – United States, February

Open access